TB 500 2mg

In stock

Lab tested · Nov 2024
£19.95

Supplied for Research Purposes Only. This product and the information provided are intended solely for laboratory research. We do not provide guidance on human use. These products are for sale to persons aged 18 and over only. Customers are responsible for checking the legal status of the product in their own jurisdiction before purchase.

TB-500 2mg is supplied as a thymosin-related research peptide vial. Its research context includes peptide-fragment identification and metabolism, alongside wider scientific interest in thymosin beta-4 and cell-movement biology.

Check out our Independent Lab Analysis (opens in a new window).

For information on reconstituting peptides, see our guide: How to Reconstitute Peptides with Bacteriostatic Water: A Step-by-Step Guide .

Choose your TB-500

Available as a 2mg, 5mg or 10mg vial, a 10mg pen or 30 tablets.

Vialspowder

  • This page
    This page

    TB-500 2mg Vial

    £19.95 In stock
    You're viewing this one

Penpre-filled

Tablets

Certificate of analysis

Independently tested by MZ Biolabs

All lab reports
View full certificate from 7 November 2024 (PDF, opens in a new tab)

Latest result

Most recent test
  • 95.66% Purity
  • 1.91 mg Calculated amount 95.66% purity of 2 mg
Sample tested
Not stated
Analysis date
7 November 2024
Laboratory
MZ Biolabs
Lab lot
2024-10-30
Identity
Molecular weight confirmed
Method
HPLC-UV-MS

Testing history

  1. 7 November 2024 Purity 95.66% PDF
  2. 1 March 2023 Purity 97.2% PDF
  3. 16 June 2021 Purity 98.8% PDF

TB-500 and thymosin-related research

TB-500 2mg is associated with the thymosin beta-4 research field, which explores the relationship between peptide structure, cellular movement and tissue responses. Direct TB-500 studies also provide useful analytical information about fragment identity and metabolism.

The fragment studied in the literature

Researchers have identified N-acetylated LKKTETQ in a preparation called TB-500. This seven-amino-acid sequence corresponds to residues 17-23 within thymosin beta-4. Establishing that structure allows experimental findings to be connected to a defined molecule, rather than relying on a product name alone.

In equine research, liquid chromatography and mass spectrometry detected the fragment and its metabolites after administration. The work contributes to understanding peptide breakdown and provides methods for recognising the material in biological samples.

Connecting the research to this listing

TB-500 is also used commercially in association with full-length thymosin beta-4. The supplied information for this 2mg vial does not include sequence-level confirmation, so the fragment and full-length identities are kept distinct here.

Cell-movement and repair research involving the parent peptide provides scientific background, while claims about human recovery require direct evidence for the actual material. The 2mg amount identifies this quantity variant without implying a different biological action.

Also known as

  • TB-500
  • TB500

Products are supplied for research purposes only and are for sale to persons aged 18 and over.